Matthew W. Davis - 03 Nov 2025 Form 3 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Signature
/s/ Lori Braender, as Attorney-In-Fact
Issuer symbol
AQST
Transactions as of
03 Nov 2025
Net transactions value
$0
Form type
3
Filing time
12 Nov 2025, 09:34:20 UTC
Next filing
12 Nov 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Davis Matthew W. Chief Development Officer C/O AQUESTIVE THERAPEUTICS, INC., 30 TECHNOLOGY DRIVE, WARREN /s/ Lori Braender, as Attorney-In-Fact 12 Nov 2025 0002094283

No securities are beneficially owned.